Twitter prank spurs unexpected scrutiny of insulin prices
A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis — a new wave of scrutiny of the high cost of its insulin. Authentic-looking fake accounts proliferated last week after Twitter rolled out a paid verification service, the latest in a string of chaotic developments since … Read more